Nano-X Imaging (NASDAQ:NNOX) Price Target Cut to $9.00 by Analysts at Cantor Fitzgerald

Nano-X Imaging (NASDAQ:NNOXGet Free Report) had its price objective dropped by equities research analysts at Cantor Fitzgerald from $12.00 to $9.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price points to a potential upside of 77.69% from the stock’s current price.

Separately, D. Boral Capital restated a “buy” rating and set a $15.00 price objective on shares of Nano-X Imaging in a report on Monday.

Read Our Latest Report on NNOX

Nano-X Imaging Stock Performance

Shares of NASDAQ NNOX traded up $0.07 during trading on Tuesday, hitting $5.07. 624,940 shares of the company traded hands, compared to its average volume of 1,744,823. The firm has a market capitalization of $292.65 million, a price-to-earnings ratio of -5.94 and a beta of 1.99. The business’s fifty day moving average is $6.55 and its 200 day moving average is $6.64. Nano-X Imaging has a fifty-two week low of $4.61 and a fifty-two week high of $11.39.

Nano-X Imaging (NASDAQ:NNOXGet Free Report) last posted its quarterly earnings results on Monday, March 31st. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.08). The firm had revenue of $3.00 million for the quarter, compared to analyst estimates of $3.80 million. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. On average, analysts predict that Nano-X Imaging will post -0.92 EPS for the current year.

Institutional Investors Weigh In On Nano-X Imaging

Several institutional investors have recently bought and sold shares of NNOX. Intech Investment Management LLC purchased a new position in Nano-X Imaging during the third quarter worth about $124,000. Verition Fund Management LLC bought a new position in shares of Nano-X Imaging during the 3rd quarter valued at approximately $88,000. State Street Corp increased its stake in shares of Nano-X Imaging by 2.1% during the 3rd quarter. State Street Corp now owns 983,305 shares of the company’s stock worth $5,978,000 after purchasing an additional 20,279 shares during the last quarter. Barclays PLC raised its holdings in shares of Nano-X Imaging by 258.5% in the 3rd quarter. Barclays PLC now owns 86,181 shares of the company’s stock worth $523,000 after purchasing an additional 62,140 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Nano-X Imaging by 2.2% during the third quarter. Geode Capital Management LLC now owns 677,853 shares of the company’s stock valued at $4,121,000 after purchasing an additional 14,560 shares during the period. Institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.

Featured Articles

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.